Nabriva Therapeutics' Series B Round

Nabriva Therapeutics raised a round of funding on April 07, 2015.

Nabriva Therapeutics is a biotechnology company focused on developing a new class of antibiotics, the pleuromutilins, for the treatment of patients with serious infections caused by multi-drug resista…

Articles about Nabriva Therapeutics' Series B Round: